Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism?
- PMID: 14966174
- PMCID: PMC1738989
- DOI: 10.1136/jnnp.2003.019331
Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism?
Abstract
Background/aim: Blepharospasm (BEB) and hemifacial spasm (HFS) appear to be distinct disorders. Clinical characteristics of coexistent BEB and HFS have not been examined. The aim of this study was to determine the prevalence, clinical, and imaging features of coexistent BEB among a cohort of HFS patients and controls.
Results: Among 665 study subjects, nine (5.5%) of the 164 consecutive HFS patients had coexistent BEB, significantly higher than age and gender matched controls (0/501, 0%) without neurological diseases (p<0.0001). The mean age of the nine patients was 61.4 (SD 9.9) (range 51-72), consisting of 88.9% women, and 66.7% had left sided HFS, similar to HFS patients without BEB. Six (66.7%) reported BEB symptoms at a mean of 0.8 years after HFS onset, one before, and onset was undetermined in two patients. Advanced magnetic resonance imaging and angiography revealed neurovascular compression of the ipsilateral side of HFS, without any basal ganglia lesions.
Conclusions: BEB occurred more frequently in HFS patients, suggesting changes in the brainstem blink reflex circuitry could play a modulatory role in certain at-risk individuals resulting in the coexistence of these movement disorders.
Similar articles
-
Facial dystonias and rosacea: is there an association?Orbit. 2014 Aug;33(4):276-9. doi: 10.3109/01676830.2014.904379. Epub 2014 May 15. Orbit. 2014. PMID: 24831933 Review.
-
Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.Clin Exp Ophthalmol. 2010 Oct;38(7):688-91. doi: 10.1111/j.1442-9071.2010.02303.x. Epub 2010 Jul 21. Clin Exp Ophthalmol. 2010. PMID: 20456439
-
Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.PLoS One. 2016 Dec 16;11(12):e0168652. doi: 10.1371/journal.pone.0168652. eCollection 2016. PLoS One. 2016. PMID: 27992533 Free PMC article.
-
Benign essential blepharospasm: risk factors with reference to hemifacial spasm.J Neuroophthalmol. 2005 Dec;25(4):280-5. doi: 10.1097/01.wno.0000189063.43423.04. J Neuroophthalmol. 2005. PMID: 16340493
-
Chemodenervation for the Treatment of Facial Dystonia: A Report by the American Academy of Ophthalmology.Ophthalmology. 2018 Sep;125(9):1459-1467. doi: 10.1016/j.ophtha.2018.03.013. Epub 2018 Apr 10. Ophthalmology. 2018. PMID: 29653859 Review.
Cited by
-
Hemifacial Spasm and Blepharospasm: Divergent Social Cognition Performance Despite Similar Neurocognitive Profiles.Brain Behav. 2025 Aug;15(8):e70794. doi: 10.1002/brb3.70794. Brain Behav. 2025. PMID: 40847443 Free PMC article.
-
Altered Functional Connectivity and Sensory Processing in Blepharospasm and Hemifacial Spasm: Coexistence and Difference.Front Neurol. 2021 Dec 15;12:759869. doi: 10.3389/fneur.2021.759869. eCollection 2021. Front Neurol. 2021. PMID: 34975723 Free PMC article.
-
Cortico-basal ganglia networks dysfunction associated with disease severity in patients with idiopathic blepharospasm.Front Neurosci. 2023 Mar 30;17:1159883. doi: 10.3389/fnins.2023.1159883. eCollection 2023. Front Neurosci. 2023. PMID: 37065925 Free PMC article.
-
Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.J Neural Transm (Vienna). 2010 Jun;117(6):765-72. doi: 10.1007/s00702-010-0416-5. Epub 2010 May 14. J Neural Transm (Vienna). 2010. PMID: 20467763 Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources